Teleflex launches Rusch DispoLED laryngoscope handle Teleflex Incorporated has announced the launch of the Rusch DispoLED Single-Use Fiber Optic Laryngoscope Handle, a way to combat cross-contamination infection risk during intubation.
Teleflex premium valuation justified, says Brean Capital Brean Capital believes Teleflex deserves to trade at a premium following the company's analyst day. The firm cited the company strategy and long term financial goals, free cash flow growth expectations, and operating margin expansion potential. Brean Capital reiterated its Buy rating and raised its price target to $135 from $129 on Teleflex shares.
Teleflex sees constant currency revenue growth of 5%-6% per year in 2016-2018 The company’s longer-term financial goals and objectives include constant currency revenue growth of between 5%-6% per year for 2016 through 2018; adjusted gross and operating margin expansion of 350 basis points to 400 basis points beyond 2015 levels by 2018; and free cash flow growth of between 10%-12% per year through 2018.